Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Publication

Crosstalk between CLCb/Dyn1-Mediated Adaptive Clathrin-Mediated Endocytosis and Epidermal Growth Factor Receptor Signaling Increases Metastasis.

Developmental cell | 2017

Signaling receptors are internalized and regulated by clathrin-mediated endocytosis (CME). Two clathrin light chain isoforms, CLCa and CLCb, are integral components of the endocytic machinery whose differential functions remain unknown. We report that CLCb is specifically upregulated in non-small-cell lung cancer (NSCLC) cells and is associated with poor patient prognosis. Engineered single CLCb-expressing NSCLC cells, as well as "switched" cells that predominantly express CLCb, exhibit increased rates of CME and altered clathrin-coated pit dynamics. This "adaptive CME" resulted from upregulation of dynamin-1 (Dyn1) and its activation through a positive feedback loop involving enhanced epidermal growth factor (EGF)-dependent Akt/GSK3β phosphorylation. CLCb/Dyn1-dependent adaptive CME selectively altered EGF receptor trafficking, enhanced cell migration in vitro, and increased the metastatic efficiency of NSCLC cells in vivo. We define molecular mechanisms for adaptive CME in cancer cells and a role for the reciprocal crosstalk between signaling and CME in cancer progression.

Pubmed ID: 28171750 RIS Download

Research resources used in this publication

None found

Additional research tools detected in this publication

None found

Antibodies used in this publication

Associated grants

Agency: NIGMS NIH HHS, United States
Id: R01 GM042455
Agency: NIGMS NIH HHS, United States
Id: R01 GM073165
Agency: NIMH NIH HHS, United States
Id: R01 MH061345

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.

Monoclonal Anti-Vinculin antibody produced in mouse (antibody)

RRID:AB_477629

This monoclonal targets Vinculin antibody produced in mouse

View all literature mentions

Anti-β-Actin antibody, Mouse monoclonal (antibody)

RRID:AB_476692

This monoclonal targets β-Actin

View all literature mentions

Rabbit Anti-APPL1 Monoclonal Antibody, Unconjugated, Clone D83H4 (antibody)

RRID:AB_2056989

This monoclonal targets APPL1

View all literature mentions

tuberin (C-20) (antibody)

RRID:AB_632569

This polyclonal targets TSC2

View all literature mentions

Phospho-Tuberin (pTSC-2) (antibody)

RRID:AB_329855

This unknown targets Polyclonal antibodies are produced by immunizing rabbits with a synthetic phospho-peptide (KLH-coupled) corresponding to residues surrounding Thr1462 of human tuberin.

View all literature mentions